
==== Front
Mediterr J Hematol Infect Dis
Mediterr J Hematol Infect Dis
Mediterranean Journal of Hematology and Infectious Diseases
Mediterranean Journal of Hematology and Infectious Diseases
2035-3006
Università Cattolica del Sacro Cuore

10.4084/MJHID.2024.069
mjhid-16-1-e2024069
Scientific Letters
Hb H Disease Caused by Uniparental Disomy: First Report of the αT-Saudiα Mutation in the Chinese Population
Wang Ge Resources 2*
Xie Hongting Conceptualization Data curation Methodology Writing - original draft 1*
Zhang Jun Formal analysis 3
Huang Peng Formal analysis 4
Liang Min Formal analysis 3
Zhu Dina Validation 5
Zhang Qianqian Validation 1
Zhou Yuqiu Resources 2
Shang Xuan Conceptualization Writing - review & editing 1678
1 Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
2 Zhuhai Institute of Medical Genetics, Zhuhai Center for Maternal and Child Health Care, Zhuhai, Guangdong, China
3 Department of Obstetrics, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
4 Prenatal Diagnostic Center, Institute of Birth Defect Prevention and Control, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
5 Prenatal Diagnosis Center, Department of Obstetrics and Gynecology, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
6 Guangdong Provincial Key Laboratory of Single Cell Technology and Application, Guangzhou, China
7 Innovation Center for Diagnostics and Treatment of Thalassemia, Nanfang Hospital, Southern Medical University, Guangzhou, China
8 Guangxi Key Laboratory of Precision Medicine for Genetic Diseases, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
Correspondence to: Dr. Xuan Shang, Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China. E-mail: shangrabbit@163.com; shang80@smu.edu.cn
* These authors contributed equally to this work.

2024
01 9 2024
16 1 e202406928 7 2024
07 8 2024
2024
https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Hb H disease
Uniparental disomy
α
T-Saudiα
Ethnic-specific variants
National Natural Science Foundation of China82370122 Guangdong Basic and Applied Basic Research Foundation2024A1515012748 Guangxi Key Laboratory of Precision Medicine for Genetic Diseases of Maternal and Child Health Hospital of Guangxi Zhuang Autonomous RegionGXWCH-ZDKF-2023–11
==== Body
pmcTo the editor.

Thalassemia is one of the most common monogenic disorders worldwide.1 It shows an autosomal recessive Mendelian pattern of inheritance, which means that thalassemia patients should be homozygous or compound heterozygous of pathogenic mutations, and their parents should be heterozygotes of mutations.2 However, in some families with thalassemia, the patient has only one parent who is a mutation carrier, which is discrepant with the Mendelian law. Other than non-paternity, this situation can be caused by two mechanisms: (i) A de novo mutation occurring in the child.2,3 In this status, the child is generally a compound heterozygote. (ii) Uniparental disomy (UPD), in which the child inherits a pair of chromosomes from only one parent. In this scenario, the child is always a homozygote. There are three patterns of UPD: a patient can have two identical copies of the same chromosome (uniparental isodisomy, iUPD), two homologous chromosomes from the same parent (uniparental heterodisomy, hUPD), or a mixture of iUPD and hUPD. A recent study estimated the overall prevalence of UPD at birth to be approximately 1/2000.4

Here, we reported a Chinese female with Hb H disease who was homozygous for the αT-Saudiα mutation as a result of UPD. We explored a possible mechanism for its generation as it displayed a relatively complex structure with uniparental maternal heterodisomy and isodisomy. Moreover, while the αT-Saudiα mutation is a well-known ethnic-specific variant in the Arabian population,5 this is the first time it has been detected in the Chinese population.

The patient (II-4) was a pregnant 25-year-old woman who lived in Guangdong Province in South China, a region of high thalassemia prevalence.6 However, she was born in Shanxi Province in northwest China, a region where thalassemia is not endemic. During the obstetrical examination process, she was diagnosed with Hb H disease on the basis of moderate anemia with microcytosis and hypochromia, a reduced HbA2 level, and the existence of the presence of Hb H and Hb Bart’s in peripheral blood cells (Table 1). She had no symptoms of splenomegaly, hepatomegaly, jaundice or iron deficiency, and she did not receive any blood transfusions. A routine test for common mutations associated with α-thalassemia in a local hospital in Guangdong showed negative results. Her family (Figure 1A) was referred to our laboratory for further analysis. Written informed consent was obtained in accordance with the Declaration of Helsinki. A detailed family history was collected, and the pure Chinese origin of the family was confirmed at least 5 generations back, with no record of migration marriage.

The hematological data from this family are shown in Table 1. The patient’s mother and three siblings all presented microcytic hypochromic parameters with normal hemoglobin levels and reduced or borderline Hb A2 levels, consistent with the clinical characteristics of the α-thalassemia trait, while the father showed a normal phenotype. Sanger sequencing (Figure 1B and Supplementary Figure 1) revealed the presence of the αT-Saudiα mutation (HBA2: c.*94A>G) in this family, including a homozygous in the patient and a heterozygous result in her mother and three siblings, whereas a normal result in her father. αT-Saudiα is a non-deletional α-thalassemia mutation occurring in the poly-A signal of the α2-globin gene (AATAAA>AATAAG). Previous research5 demonstrated that homozygotes for this mutation present with typical Hb H disease (Hb ranges: 74–97 g/L and Hb H level:7.5%–27.2%). Therefore, the α-globin genotype data of all family members are in accordance with their phenotypes. Puzzlingly, however, the patient is a homozygote, while her father does not carry this mutation. Multiplex ligation-dependent probe amplification (MLPA) analysis excluded the existence of deletions (data not shown). Therefore, we speculated that the homozygous state might have been caused by UPD. Genome-wide single nucleotide polymorphism (SNP) genotyping analysis was performed using the Illumina Human Omni Zhonghua-8 BeadChip in the proband and her parents. UPD analysis of the patient was carried out using genotype data in a trio. The results (Figure 1C) showed that there were two maternal heterodisomic regions and two maternal isodisomic regions on chromosome 16. Therefore, we confirm that this case of Hb H disease was caused by maternal UPD.

To date, a total of 12 cases of hemoglobinopathy caused by UPD have been reported (Supplementary Table 1). Seven cases, comprising six cases of thalassemia major and one case of abnormal hemoglobin, were due to UPD on chromosome 11 encompassing the β-globin gene. Five cases, comprising three cases of Hb Barts hydrops foetalis, one case of Hb H disease (our case) and one case of abnormal hemoglobin, were due to UPD on chromosome 16 encompassing the α-globin gene.7–10 When comparing our data with previously published data, we inferred that our case is only one with iUPD at the distal p (short arm) and distal q (long arm) segment and hUPD at the pericentromeric region. In addition, among the 5 cases of UPD related to α-globin, 2 of them mentioned that possible mechanism leading to UPD is nondisjunction error at maternal meiosis I. Therefore, we further investigated the mechanism of UPD formation in our case.

Mechanisms that result in UPD include trisomy rescue, gamete complementation, monosomy rescue and somatic recombination.11 Monosomy rescue leads to complete isodisomy, and gamete complementation produces complete heterodisomy. Considering that our case has partial heterodisomy and partial isodisomy, the above two mechanisms can be ruled out. Somatic recombination always results in mosaicism. Analysis of DNA from our patient’s hair follicle and oral mucosal cell DNA was consistent with the testing of her blood cells, which excludes the existence of mosaicism in somatic cells and indicates that trisomy rescue is the only possible mechanism.

Moreover, our case had heterodisomic and isodisomic regions, suggesting the occurrence of homologous recombination events at multiple sites and segregation error events in meiosis.12 Nondisjunction error can occur in both meiosis I and meiosis II. Based on this situation, recombination occurs at distal short arm and distal long arm fragments if nondisjunction takes place in meiosis I. In contrast, if nondisjunction takes place in meiosis II, recombination occurs at pericentromeric fragments. Since the pericentromeric region is often suppressed for recombination, nondisjunction is very unlikely to occur in meiosis II. Therefore, we propose that nondisjunction can occur during meiosis I and then due to trisomy rescue, resulting in uniparental disomy, as shown in Figure 1D.

In previously published data, all known individuals carrying this mutation (Supplementary Table 2) were distributed either in countries in the Middle East or in countries with a large Arabian population (Figure 2). Previous studies have confirmed that the αT-Saudiα mutation is one of the major α-thalassemia determinants in the population of the Arabian Peninsula.5 Therefore, this mutation can be regarded as an ethnic-specific variant in the Arabian population. However, it is the first identification of the αT-Saudiα mutation in the Chinese population, and we speculated that it is population migration that results in ethnic-specific mutations spread to other populations.

In summary, we have identified the detailed UPD pattern in this patient with Hb H disease and have analyzed the mechanism by which it originated. These data may be valuable for providing accurate diagnoses in similar cases. In addition, this case could be used as new evidence substantiating the gene flow between the Chinese population and another population in ancient times.

Supplementary Information

Acknowledgements

We thank the patient and her family for their reliance and cooperation.

Availability of data and materials

The data in the current study are available within the article and its supplementary materials. The variant has been submitted to ClinVar under Accession: VCV000375749.61 (https://www.ncbi.nlm.nih.gov/clinvar/variation/375749/?oq=HBA2:%20c.*94A%3EG&m=NM_000517.6(HBA2):c.*94A%3EG)

List of abbreviations and HGVS name of the variants

UPD uniparental disomy

iUPD uniparental isodisomy

hUPD uniparental heterodisomy

SNP single nucleotide polymorphism

MLPA multiplex ligation-dependent probe amplification

NDJ nondisjunction

Hb hemoglobin

MCV mean corpuscular volume

MCH mean corpuscular hemoglobin

--MED including --MED ‡T (NG_000006.1:g.24664_41064del16401) and –MED ‡U (NG_000006.1:g.10864_40864del30001)

Figure 1 The patient is homozygous for the αT-Saudiα mutation, and her homozygous state is due to maternal UPD

(A) The pedigree of the family. The arrow indicates the patient (II-4).) (B) Sanger sequencing results for samples of peripheral blood cells (I-1, I-2, II-1 and II-4) as well as oral mucosal epithelium and hair follicles (II-4). The red box indicates the mutation site. (C) The SNP array result revealed maternal uniparental isodisomy and heterodisomy on chromosome 16. Smooth Log R ratio (red line) shows the SNP intensity and represents the allelic copy number. B-allele frequency (blue dots) displays genotyping information. (D) Possible mechanism to explain the formation of the UPD pattern in II-4. NDJ: nondisjunction.

Figure 2 Geographic distribution of known individuals carrying the αT-Saudiα mutation

The yellow star represents the case in this study.

Table 1 Summary of hematological and genotype data.

Subject	Gender/a ge	Hb (g/L)	MCV (fL)	MCH (pg)	Hb A2 (%)	Hb H (%)	Hb Bart’s (%)	α-Genotype	
‡T-1	M/53	172	90.8	27.8	2.7	-	-	αα/αα	
‡T-2	F/52	128	70.7↓	22.3↓	2.8	-	-	αT-Saudiα/αα	
‡U-1	F/31	124	68.2↓	21.5↓	2.2↓	-	-	αT-Saudiα/αα	
‡U-2	M/29	154	74.9↓	24.1↓	2.7	-	-	αT-Saudiα/αα	
‡U-3	F/28	108↓	62.5↓	18.5↓	2.1↓	-	-	αT-Saudiα/αα	
‡U-4	F/25	90↓	58.5↓	17.9↓	0.7↓	21.6↑	2.1↑	αT-Saudiα/α T-Saudiα	
Hb: hemoglobin; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; -: not detected. Reference value: Hb 130–175 g/L for males, 115–150 g/L for females; MCV 80–100 fL; MCH 27–34 pg; Hb A2 2.5–3.5%; Hb H 0%; Hb Bart’s 0%.

Competing interests: The authors declare no conflict of Interest.

The reference sequence of HBA2 is from NC_000016.10, GRCh38.

Ethics approval and consent to participate: This study was approved by the Ethics Committee of Zhuhai Women and Children’s Hospital (number IRB-2020081401). We certify that the study was performed in accordance with the 1964 Declaration of Helsinki and later amendments. Written informed consent was obtained from all the participants prior to enrollment in this study.

Consent for publication: Written informed consent was obtained from the patient and her parents for publication of this Case report and any accompanying images.

CRediT authorship contribution statement: Ge Wang, Yuqiu Zhou: Resources. Hongtiong Xie: Conceptualization, Data curation, Methodology, Writing – original draft. Jun Zhang, Peng Huang, Min Liang: Formal analysis, DinaZhu, Qianqian Zhang: Validation. Xuan Shang: Conceptualization, Writing – review and editing.

Funding: This work was supported by National Natural Science Foundation of China (82370122), Guangdong Basic and Applied Basic Research Foundation (2024A1515012748) and open foundation from Guangxi Key Laboratory of Precision Medicine for Genetic Diseases of Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region(GXWCH-ZDKF-2023–11).
==== Refs
References

1 Angastiniotis M Eleftheriou A Galanello R Harteveld CL Petrou M Traeger-Synodinos J Old J Prevention of Thalassaemias and Other Haemoglobin Disorders: Volume 1: Principles Nicosia (Cyprus) Thalassaemia International Federation © 2013 Thalassaemia International Federation 2013
2 Shang X Xu X Update in the genetics of thalassemia: What clinicians need to know Best Pract Res Clin Obstet Gynaecol 2017 39 3 15 10.1016/j.bpobgyn.2016.10.012 27876354
3 Zhu C Yu W Xie J Chen L Ding H Shang X Hemoglobin H disease due to a de novo mutation at the α2-globin gene and an inherited common α-thalassemia deletion found in a Chinese boy Blood Cells Mol Dis 2010 45 3 223 6 10.1016/j.bcmd.2010.07.005 20691621
4 Nakka P Pattillo Smith S O’Donnell-Luria AH McManus KF Mountain JL Ramachandran S Characterization of Prevalence and Health Consequences of Uniparental Disomy in Four Million Individuals from the General Population Am J Hum Genet 2019 105 5 921 32 10.1016/j.ajhg.2019.09.016 31607426
5 Al Moamen NJ Thabet A Mahdi F Newton H Salman E Various α-Thalassemia Genotype Combinations of the Saudi-Type Polyadenylation Signal Mutation (αT-Saudiα) in the Population of Bahrain: An Update of Genotype-Phenotype Analyses Hemoglobin 2018 42 3 166 70 10.1080/03630269.2018.1499523 30864492
6 Shang X Peng Z Ye Y Asan Zhang X Chen Y Rapid Targeted Next-Generation Sequencing Platform for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies EBioMedicine 2017 23 150 9 10.1016/j.ebiom.2017.08.015 28865746
7 Au PK Kan AS Tang MH Leung KY Chan KY Tang TW A Fetus with Hb Bart’s Disease Due to Maternal Uniparental Disomy for Chromosome 16 Hemoglobin 2016 40 1 66 9 10.3109/03630269.2015.1096283 26574185
8 Tan YR Tan HK A Rare Case of Hemoglobin Bart’s Hydrops Fetalis due to Uniparental Disomy of Chromosome 16 J Med Cases 2021 12 7 275 9 10.14740/jmc3693 34434471
9 Wattanasirichaigoon D Promsonthi P Chuansumrit A Leopairut J Yanatatsaneejit P Rattanatanyong P Maternal uniparental disomy of chromosome 16 resulting in hemoglobin Bart’s hydrops fetalis Clin Genet 2008 74 3 284 7 10.1111/j.1399-0004.2008.01046.x 18564363
10 Mehta N Johnston JM Hein M Kipp BR Coon L Savedra ME Further Characterization of Hb Bronovo [α103(G10)His→Leu; HBA2: c.311A>T] and First Report of the Homozygous State Hemoglobin 2020 44 3 174 8 10.1080/03630269.2020.1776322 32552204
11 Lapunzina P Monk D The consequences of uniparental disomy and copy number neutral loss-of-heterozygosity during human development and cancer Biol Cell 2011 103 7 303 17 10.1042/BC20110013 21651501
12 Benn P Uniparental disomy: Origin, frequency, and clinical significance Prenat Diagn 2021 41 5 564 72 10.1002/pd.5837 33179335
